IL17A and infection: In contrast, determination of CFUs in the lungs revealed that on Day 143 after infection with an elevated dose of Mtb H37rv, IL-17A/F−/− mice appeared to exhibit a significantly lower bacterial burden when compared with both the IL-17A−/− mice and the wildtype controls (Figure 7C).